Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo. (2014)

First Author: Heap JT
Attributed to:  Second Generation Sustainable Bacterial Biofuels funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.1761

PubMed Identifier: 24732092

Publication URI: http://europepmc.org/abstract/MED/24732092

Type: Journal Article/Review

Volume: 5

Parent Publication: Oncotarget

Issue: 7

ISSN: 1949-2553